全文获取类型
收费全文 | 890篇 |
免费 | 75篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 35篇 |
妇产科学 | 4篇 |
基础医学 | 153篇 |
口腔科学 | 30篇 |
临床医学 | 124篇 |
内科学 | 298篇 |
皮肤病学 | 5篇 |
神经病学 | 10篇 |
特种医学 | 125篇 |
外科学 | 37篇 |
综合类 | 11篇 |
预防医学 | 48篇 |
眼科学 | 2篇 |
药学 | 47篇 |
中国医学 | 2篇 |
肿瘤学 | 64篇 |
出版年
2021年 | 6篇 |
2019年 | 17篇 |
2018年 | 12篇 |
2017年 | 10篇 |
2016年 | 16篇 |
2015年 | 17篇 |
2014年 | 19篇 |
2013年 | 34篇 |
2012年 | 34篇 |
2011年 | 29篇 |
2010年 | 37篇 |
2009年 | 38篇 |
2008年 | 27篇 |
2007年 | 45篇 |
2006年 | 43篇 |
2005年 | 39篇 |
2004年 | 38篇 |
2003年 | 21篇 |
2002年 | 22篇 |
2001年 | 7篇 |
2000年 | 18篇 |
1999年 | 18篇 |
1998年 | 29篇 |
1997年 | 34篇 |
1996年 | 29篇 |
1995年 | 25篇 |
1994年 | 27篇 |
1993年 | 20篇 |
1992年 | 14篇 |
1991年 | 12篇 |
1990年 | 10篇 |
1989年 | 17篇 |
1988年 | 17篇 |
1987年 | 13篇 |
1986年 | 17篇 |
1985年 | 16篇 |
1984年 | 9篇 |
1983年 | 8篇 |
1982年 | 14篇 |
1981年 | 12篇 |
1980年 | 7篇 |
1979年 | 9篇 |
1978年 | 12篇 |
1977年 | 5篇 |
1976年 | 7篇 |
1975年 | 14篇 |
1974年 | 5篇 |
1972年 | 5篇 |
1969年 | 7篇 |
1933年 | 5篇 |
排序方式: 共有996条查询结果,搜索用时 15 毫秒
991.
Dejan Reljic Walburga Dieterich Hans J. Herrmann Markus F. Neurath Yurdagül Zopf 《Nutrients》2022,14(10)
Exercise is a cornerstone in metabolic syndrome (MetS) treatment. However, the effects of low-volume exercise modalities on MetS-associated low-grade inflammation are unclear. A total of 106 MetS patients (53.7 ± 11.4 years) were randomized to low-volume high-intensity interval training (LOW-HIIT, 14 min/session), single-set resistance training (1-RT, ~15 min/session), whole-body electromyostimulation (WB-EMS, 20 min/session), three-set resistance training (3-RT, ~50 min/session), each performed 2 ×/week for 12 weeks, or a control group (CON). All groups received nutritional counseling for weight loss. Inflammatory and cardiometabolic indices were analyzed pre- and post-intervention. All groups significantly reduced body weight by an average of 3.6%. Only LOW-HIIT reduced C-reactive protein (CRP) (−1.6 mg/L, p = 0.001) and interleukin-6 (−1.1 pg/mL, p = 0.020). High-sensitivity CRP and lipopolysaccharide-binding protein decreased following LOW-HIIT (−1.4 mg/L, p = 0.001 and −2.1 ng/mL, p = 0.004) and 3-RT (−0.6 mg/L, p = 0.044 and −2.0 ng/mL, p < 0.001). MetS severity score improved with LOW-HIIT (−1.8 units, p < 0.001), 1-RT (−1.6 units, p = 0.005), and 3-RT (−2.3 units, p < 0.001). Despite similar effects on body weight, low-volume exercise modalities have different impact on inflammatory and cardiometabolic outcomes in MetS patients. LOW-HIIT has superior efficacy for improving inflammation compared to 1-RT and WB-EMS. Resistance-based exercise appears to require a higher volume to promote beneficial impact on inflammation. 相似文献
992.
993.
994.
Dr. Rudolf Neurath 《Journal of molecular medicine (Berlin, Germany)》1924,3(9):337-339
Ohne Zusammenfassung 相似文献
995.
996.
Silvia Spoerl Anita N. Kremer Michael Aigner Nina Eisenhauer Pauline Koch Lina Meretuk Patrick Löffler Matthias Tenbusch Clara Maier Klaus Überla Lucie Heinzerling Benjamin Frey Gloria Lutzny-Geier Thomas H. Winkler Gerhard Krönke Marcel Vetter Heiko Bruns Markus F. Neurath Andreas Mackensen Andreas E. Kremer Simon Völkl 《European journal of immunology》2021,51(6):1436-1448
COVID-19 is a life-threatening disease leading to bilateral pneumonia and respiratory failure. The underlying reasons why a smaller percentage of patients present with severe pulmonary symptoms whereas the majority is only mildly affected are to date not well understood. Comparing the immunological phenotype in healthy donors and patients with mild versus severe COVID-19 shows that in COVID-19 patients, NK-/B-cell activation and proliferation are enhanced independent of severity. As an important precondition for effective antibody responses, T-follicular helper cells and antibody secreting cells are increased both in patients with mild and severe SARS-CoV-2 infection. Beyond this, T cells in COVID-19 patients exhibit a stronger activation profile with differentiation toward effector cell phenotypes. Importantly, when looking at the rates of pulmonary complications in COVID-19 patients, the chemokine receptor CCR4 is higher expressed by both CD4 and CD8 T cells of patients with severe COVID-19. This raises the hypothesis that CCR4 upregulation on T cells in the pathogenesis of COVID-19 promotes stronger T-cell attraction to the lungs leading to increased immune activation with presumably higher pulmonary toxicity. Our study contributes significantly to the understanding of the immunological changes during COVID-19, as new therapeutic agents, preferentially targeting the immune system, are highly warranted. 相似文献